Advertisement

Topics

Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

06:40 EDT 26th September 2016 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 350,000+

Monday 26th September 2016

GSK files for approval of subcutaneous lupus drug

GlaxoSmithKline has filed for approval of a subcutaneous formulation of its lupus drug Benlysta on both sides of the Atlantic.

NICE clears Gilead’s pan-genotypic hep C drug Epclusa

The National Institute for Health and Care Excellence is endorsing Gilead's pan-genotypic hepatitis C drug Epclusa for routine NHS use in England and Wales.

Latest SBRI comp offers £1.1m for GP innovations

NHS England investment fund SBRI Healthcare has launched its autumn competition offering entrepreneurs the opportunity for funding to drive forward their innovations within general practice.

Allergy Therapeutics half yearly revenues grow amid market turmoil

Allergy Therapeutics plc (LON:AGY) saw revenues grow 12% to £48.5mln for the six months ended June.   But a £16.2mln research and development spending drive meant losses widened to £13mln, resulting in losses per share of 2.29p. Allergy Therapeutics said the global allergy treatment market had seen some “turmoil” affecting the competitive market environment in Europe and the US, bu...

Ergomed upbeat as drug safety arm powers ahead

Ergomed Plc (LON:ERGO) increased interim revenues by more than a fifth on the back another strong half year for its drug safety and information business Primevigilance. Revenues at the clinical services specialist rose to £17.6mln (£14.5mln), with Primevigilance chipping in £5.5mln, a 53% jump on a year earlier. Underlying profits [EBITDA] rose 12% to £1.9mln, though pre-tax profits dipped...

Concepta signs Chinese manufacturing deal

Women's infertility treatment developer Concepta PLC (LON:CPT) has done a deal to make its products in China. Concepta has signed a manufacturing agreement with Shijiazhuang Huanzhong Biotech Limited to assemble and package Concepta’s My Lotus fertility product. The company said the deal was in line with its strategy to launch My Lotus for unexplained infertility in China in the second half ...

XFRA F8S: AUSSETZUNG/SUSPENSION

DAS FOLGENDE INSTRUMENT IST AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT IS SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORT CODE ISIN BIS/UNTIL Biotie Therapies OY F8S FI0009011571...

FDA approves expanded use of Novartis’ Ilaris to treat three rare periodic fever syndromes

Novartis has secured three new approvals from the US Food and Drug Administration (FDA) for the expanded use of Ilaris (canakinumab) to treat three rare types of Periodic Fever Syndromes.

Paion Aktie: Was kommt jetzt?

Bei der Paion Aktie werden immer wieder mal gerne charttechnische Breaks in der Folge wieder "einkassiert". In der vergangenen Woche konnte der Aktienkurs des Aachener Biotechunternehmens erneut bu...

FDA approves the first Humira biosimilar

US regulators have issued a green light for the first biosimilar of AbbVie's biologic Humira, the world second best-selling drug.

Fatal tombstones, goat men and "mirror scratching"

The laureates are once again awarded for their on the first, and often also on further, glance(s) nonsense studies in several areas of research. This is a short overview. Reproduction Prize (Egypt): The late Ahmed Shafik, for studying the effects of wearing polyester, cotton, or wool trousers on t...

New study provides strongest evidence that oxygen levels were key to evolution of early animals

It has long puzzled scientists why, after 3 billion years of nothing more complex than algae, complex animals suddenly started to appear on Earth. Now, a team of researchers has put forward some of the strongest evidence yet to support the hypothesis that high levels of oxygen in the oceans were cru...

Paion: Das sieht gut aus! Die Ausgangsposition könnte sich jetzt verändern!

Paion hat sich in nur vier Handelstagen von 2,20 Euro auf über 2,50 Euro bewegt und im Tagesverlauf am Freitag dabei auch den Widerstand bei 2,52 Euro übersprungen. Zum Handelsschluss steht die Akt...

Swedish Orphan Biovitrum AB: Alprolix Obtains Reimbursement across the United Kingdom

Swedish Orphan Biovitrum AB (publ) (Sobi™) (http://www.sobi.com/) (STO:SOBI) today announces that the company's product Alprolix® (eftrenonacog alfa), a recombinant human factor IX Fc-fusion prote...

Biotie Therapies Oyj: ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED

BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 26 September 2016, at 9.30 a.m. (EET) THE ARBITRAL TRIBUNAL HAS CONFIRMED ACORDA THERAPEUTICS, INC.'S REDEMPTION RIGHT REGARDING THE SHARES IN BIOTIE ...

Medigene Aktie vor dem Befreiungsschlag?

Der Biotechkonzern Medigene kündigt am Montagmorgen die Teilnahme an mehreren Konferenzen an. Im Gegensatz zum Aktienkurs von Paion, der in der vergangenen Woche von einer solchen Ankündigung des A...

DGAP-News: BRAIN AG ruft erfahrenen Corporate Finance Spezialisten in den Vorstand (deutsch)

BRAIN AG ruft erfahrenen Corporate Finance Spezialisten in den Vorstand DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Schlagwort(e): Personalie BRAIN AG ruft erfahrenen...

Swedish Orphan Biovitrum AB: Milan Zdravkovic joins Sobi as Senior Vice President, Head of Research & Development

Regulatory News: Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) (STO: SOBI) today announced that Milan Zdravkovic has been appointed Senior Vice President, Head of Research Deve...

Nasdaq Helsinki Ltd: SUSPENSION OF TRADING: BIOTIE THERAPIES CORP.

EXCHANGE NOTICE, 26 SEPTEMBER 2016 SHARES SUSPENSION OF TRADING: BIOTIE THERAPIES CORP. Trading in the shares of Biotie Therapies Corp. was suspended on the Nasdaq Helsinki today at 9:05 EET relate...

Press Release: Medigene participates at five national and international conferences

Medigene AG / Medigene participates at five national and international conferences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of th...

DGAP-News: MOLOGEN AG: Kapitalerhöhung durch Bezugsrechtsemission und Begebung einer Wandelschuldverschreibung (deutsch)

MOLOGEN AG: Kapitalerhöhung durch Bezugsrechtsemission und Begebung einer Wandelschuldverschreibung DGAP-News: MOLOGEN AG / Schlagwort(e): Kapitalmaßnahme MOLOGEN AG: Kapitalerhöhung durch Bezugsr...

Under value-based care, what is the ROI of telemedicine? “We just don’t know.”

Telehealth technology offers solutions to healthcare’s staffing and access challenges, but the economics behind it remain unclear.

FDA approves Allergan’s Natrelle Inspira cohesive breast implants

Allergan has secured approval from the US Food and Drug Administration (FDA) for its Natrelle Inspira cohesive breast implants.

Medigene AG: Medigene participates at five national and international conferences

Medigene AG / Medigene participates at five national and international conferences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of thi...

Medigene AG: Medigene nimmt an fünf nationalen und internationalen Konferenzen teil

Medigene AG / Medigene nimmt an fünf nationalen und internationalen Konferenzen teil . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den Inhalt der Mitteilung ist der Emittent v...


Quick Search
Advertisement